BIO-key(R) International, Inc. Partners Highlight Fingerprint Biometric Technology Solutions for Healthcare at HIMSS Multiple Partners Presenting BIO-key's Fingerprint Biometric Authentication Solution for EHR & EPCS WALL, NJ -- (Marketwire) -- 03/04/13 -- BIO-key International, Inc. (OTCQB: BKYI), a global leader in fingerprint biometric identification solutions, advanced mobile credentialing and identity verification technologies, today reported that the company will be attending the Health Information and Management Systems Society (HIMSS) annual meeting in New Orleans, Louisiana, March 3rd - 7th supporting our partners as they present BIO-key technology to attendees at the HIMSS conference. BIO-key will have a strong presence at HIMSS 2013, as healthcare partners such as Allscripts, Epic, IBM, CA Technologies, Caradigm, Indigo Identyware and Healthcast attending the event offer BIO-key solutions. Company partners will be offering demonstrations of integrated solutions for secure, compliant two-factor authentication. BIO-key customer McKesson will also be in attendance at HIMSS. Our fingerprint biometric technology is embedded within their AcuDoseRx(R) automated medication dispensing cabinets. BIO-key's fingerprint biometric technology offers strong authentication in addition to optimum convenience enabling healthcare providers to greatly reduce or eliminate the use of passwords, cards and tokens and increase the amount of time caring for patients. The company's software achieved top scores for speed and accuracy in the most recent National Institute for Standards of Technology (NIST) biometric evaluation. NIST sets the standards for the DEA ePrescription compliance guidelines. "The HIMSS conference allows BIO-key and our healthcare partners to co-present innovative solutions for EHR systems to the CEO's and CIO's from leading hospitals and clinics," stated Mike DePasquale, CEO, BIO-key. "The provider's frustration with passwords along with the organizations requirement to meet strict ePrescription compliance guidelines is motivating healthcare executives to educate themselves about the benefits of integrating BIO-key technology." About BIO-key BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com) BIO-key Safe Harbor Statement Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2011 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events. Contacts: BIO-key International, Inc. Scott Mahnken 732-359-1113
U.K. Bond Rating Affirmed at Aa1 by Moody’s After Scottish 'No' Vote
BIO-key(R) International, Inc. Partners Highlight Fingerprint Biometric Technology Solutions for Healthcare at HIMSS
Press spacebar to pause and continue. Press esc to stop.